BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:22 PM
 | 
Jun 17, 2010
 |  BC Extra  |  Top Story

OncoMed, Bayer in cancer deal

OncoMed Pharmaceuticals Inc. (Redwood City, Calif.) and Bayer AG (Xetra:BAY) partnered to discover and develop antibodies, proteins and small molecules targeting the Wnt signaling pathway to treat cancer. The deal includes OncoMed's lead...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >